Search Results
3 items found for "VIPR2"
Posts (1)
- 📰 GPCR Weekly News, February 26 to March 3, 2024
inhibition of the PKA-Hippo signaling pathway Blockade of vasoactive intestinal peptide receptor 2 (VIPR2
Other Pages (2)
- Vasoactive intestinal peptide receptor 2 signaling promotes breast cancer cell proliferation by enhancing the ERK pathway
ERK pathway Published date January 2, 2023 Abstract “ Vasoactive intestinal peptide (VIP) receptor 2 (VIPR2 Increased VIPR2 mRNA expression and/or VIPR2 gene copy number has been documented in several cancers In this study, we found that VIPR2 overexpression in MCF-7 and MDA-MB-231 cells, human breast cancer proliferation in VIPR2-overexpressing MCF-7 and MDA-MB-231 cells. kinase (ERK), which involves a VIPR2 signaling pathway through Gs protein.
- Blockade of vasoactive intestinal peptide receptor 2 (VIPR2) signaling suppresses cyclin D1-dependent cell-cycle progression in MCF-7 cells
GPCR News < GPCRs in Oncology and Immunology Blockade of vasoactive intestinal peptide receptor 2 (VIPR2 MCF-7 cells Published date March 1, 2024 Abstract "Vasoactive intestinal peptide (VIP) receptor 2 (VIPR2 In this study, we examined the role of VIPR2 in cell cycle progression. KS-133, a newly developed VIPR2-selective antagonist peptide, attenuated VIP-induced cell proliferation In MCF-7 cells stably-expressing VIPR2, KS-133 decreased PI3K activity and cAMP levels.